表紙
市場調查報告書

非侵入性產前檢查 (NIPT)的全球市場的預測 ∼2024年:各設備 (超音波、NGS、PCR、微陣列)、消耗品、手法、用途、終端用戶

Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs)-Global Forecasts to 2024

出版商 MarketsandMarkets 商品編碼 485003
出版日期 內容資訊 英文 145 Pages
訂單完成後即時交付
價格
Back to Top
非侵入性產前檢查 (NIPT)的全球市場的預測 ∼2024年:各設備 (超音波、NGS、PCR、微陣列)、消耗品、手法、用途、終端用戶 Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs)-Global Forecasts to 2024
出版日期: 2019年09月09日內容資訊: 英文 145 Pages
簡介

全球非侵入性產前檢查 (NIPT)的市場在預測期間內預計將以13.5%的年複合成長率 (CAGR) 發展,從2019年的39億美元,成長到2024年73億美元的規模。該市場的成長,由母體年齡的上升伴隨的染色體異常的風險高,無創技術較侵入性手法的偏好的趨勢高漲,NIPT的醫療費償付情形的改善,及NIPT的認知度的擴大等促進。可是,熟練的專家不足抑制著該市場的成長。

本報告提供全球非侵入性產前檢查 (NIPT)的市場調查,市場及檢驗定義和概要,對市場成長的各種影響因素及市場機會分析,各產品區分&服務、手法、用途、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • NIPT市場概要
  • NIPT市場:各用途
  • NIPT市場佔有率:各手法、地區
  • NIPT市場:地區的成長機會

第5章 市場概要

  • 簡介
    • 成長推動因素
    • 市場機會
    • 課題

第6章 NIPT市場:各產品、服務

  • 簡介
  • 產品
    • 消耗品
      • 化驗套件、試劑
      • 拋棄式品
    • 設備
      • 超音波設備
      • 次世代定序系統
      • 聚合酵素鏈鎖反應相關設備
      • 微陣列
      • 其他
  • 服務

第7章 NIPT市場:各手法

  • 簡介
  • 超音波檢測
  • 生物化學的篩檢檢驗
  • 母體血漿中的無細胞DNA的檢驗

第8章 NIPT市場:各用途

  • 簡介
  • 三染色體症
  • 微缺失症候群
  • 其他

第9章 NIPT市場:各終端用戶

  • 簡介
  • 診斷實驗室
  • 醫院

第10章 NIPT市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 法國
    • 英國
    • 德國
    • 其他
  • 亞洲
  • 其他

第11章 競爭環境

  • 概要
  • 市場參與企業的排行榜
  • 競爭領導製圖
  • 競爭情形、趨勢
    • 產品、服務投入
    • 擴張
    • 收購
    • 其他策略

第12章 企業簡介

  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • GE HEALTHCARE
  • PERKINELMER, INC.
  • AGILENT TECHNOLOGIES, INC.
  • BEIJING GENOMICS INSTITUTE
  • F. HOFFMAN-LA ROCHE LTD.
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • NATERA, INC.
  • YOURGENE HEALTH

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 5140

"Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age."

The non-invasive prenatal testing market is projected to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.

"The services segment is expected to grow at the highest CAGR during the forecast period."

Based on product and service, the NIPT market is segmented into products and services. The services segment is estimated to register the highest growth rate during the forecast period. The rising incidence of genetic disorders, increasing focus on prenatal screening, and government initiatives to provide prenatal testing services are contributing to the growth of this market.

"The diagnostic laboratories segment accounted for the largest share of the NIPT products market in 2018."

Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals. In 2018, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products. This can primarily be attributed to factors such as the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.

"Asia to witness high growth during the forecast period."

By region, the global NIPT market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2018, North America accounted for the largest market share, followed by Europe. On the other hand, Asia is expected to grow at the highest CAGR during the forecast period. The developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in Asia are driving market growth in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%)
  • By Designation: C-level (30%), D-level (34%), and Others (36%)
  • By Region: North America (40%), Europe (28%), Asia (20%), and RoW (12%)

List of Companies Profiled in the Report:

  • Illumina, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • GE Healthcare (US)
  • BGI (China)
  • Agilent Technologies, Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • PerkinElmer Inc. (US)
  • Laboratory Corporation of America Holdings (LabCorp) (US)
  • Natera, Inc. (US)
  • Yourgene Health (UK)

Research Coverage:

This report provides a picture of the global NIPT market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, and region. The NIPT products market is segmented on the basis of method and end user. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NIPT market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY SOURCES
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 NON-INVASIVE PRENATAL TESTING: MARKET OVERVIEW
  • 4.2 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION (2019-2024)
  • 4.3 NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY METHOD & REGION (2018)
  • 4.4 NON-INVASIVE PRENATAL TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • 5.1.1 DRIVERS
      • 5.1.1.1 High risk of chromosomal abnormalities with increasing maternal age
      • 5.1.1.2 Growing preference for noninvasive techniques over invasive methods
      • 5.1.1.3 Improving reimbursement scenario for NIPT
      • 5.1.1.4 Programs focusing on increasing the awareness of NIPT
    • 5.1.2 OPPORTUNITIES
      • 5.1.2.1 Untapped emerging markets
    • 5.1.3 CHALLENGES
      • 5.1.3.1 Reliability of test results, especially in obese women
      • 5.1.3.2 Lack of skilled professionals

6 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
    • 6.2.1 CONSUMABLES
      • 6.2.1.1 Assay kits & reagents
        • 6.2.1.1.1 North America is the largest market for assay kits & reagents segments
      • 6.2.1.2 Disposables
        • 6.2.1.2.1 Use of disposables to avoid contamination is one of the major growth factors for this segment
    • 6.2.2 INSTRUMENTS
      • 6.2.2.1 Ultrasound devices
        • 6.2.2.1.1 Popularity of ultrasound in fetal and embryonic imaging and safety has driven market growth
      • 6.2.2.2 Next-generation sequencing systems
        • 6.2.2.2.1 NGS systems have found rising use in NIPT
      • 6.2.2.3 Polymerase chain reaction instruments
        • 6.2.2.3.1 Increasing research in the field of prenatal genetic testing is expected to boost market growth
      • 6.2.2.4 Microarrays
        • 6.2.2.4.1 Flexibility of chips and short processing times have supported the use of microarrays
      • 6.2.2.5 Other instruments
  • 6.3 SERVICES
    • 6.3.1 NORTH AMERICA SHOWS THE HIGHEST DEMAND FOR TESTING SERVICES

7 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD

  • 7.1 INTRODUCTION
  • 7.2 ULTRASOUND DETECTION
    • 7.2.1 ULTRASOUND DETECTION SEGMENT DOMINATES THE NIPT PRODUCTS MARKET
  • 7.3 BIOCHEMICAL SCREENING TESTS
    • 7.3.1 HIGH INCIDENCE OF GENETIC DISORDERS & INCREASING FOCUS ON PRENATAL TESTING TO SUPPORT MARKET GROWTH
  • 7.4 CELL-FREE DNA IN MATERNAL PLASMA TESTS
    • 7.4.1 CELL-FREE DNA IN MATERNAL PLASMA TESTS SEGMENT TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD

8 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 TRISOMY
    • 8.2.1 TRISOMY FORMS THE LARGEST AND FASTEST-GROWING APPLICATION SEGMENT OF THE NIPT MARKET
  • 8.3 MICRODELETION SYNDROME
    • 8.3.1 HIGH INCIDENCE OF MICRODELETION SYNDROME IS A KEY FACTOR DRIVING THE GROWTH OF THIS APPLICATION SEGMENT
  • 8.4 OTHER APPLICATIONS

9 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 DIAGNOSTIC LABORATORIES
    • 9.2.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF NIPT PRODUCTS AMONG DIAGNOSTIC LABS
  • 9.3 HOSPITALS
    • 9.3.1 NORTH AMERICA HOLDS THE MAJOR SHARE OF THIS END-USER SEGMENT

10 NON-INVASIVE PRENATAL TESTING MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 High number of babies born with chromosomal syndromes is a major factor driving the demand for non-invasive prenatal testing in the US
    • 10.2.2 CANADA
      • 10.2.2.1 Unfavorable reimbursement scenario for non-invasive prenatal testing is a key challenge for market growth in Canada
  • 10.3 EUROPE
    • 10.3.1 FRANCE
      • 10.3.1.1 Favorable insurance coverage for prenatal testing to increase the adoption of NIPT in France
    • 10.3.2 UK
      • 10.3.2.1 High incidence of genetic abnormalities to increase the demand for prenatal testing procedures in the UK
    • 10.3.3 GERMANY
      • 10.3.3.1 Increasing healthcare spending-a major factor contributing to market growth in Germany
    • 10.3.4 REST OF EUROPE
  • 10.4 ASIA
    • 10.4.1 HIGH COST OF NIPT PRODUCTS IS A MAJOR FACTOR LIMITING MARKET GROWTH IN ASIA DURING THE FORECAST PERIOD
  • 10.5 REST OF THE WORLD

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 MARKET PLAYER RANKING
  • 11.3 COMPETITIVE LEADERSHIP MAPPING - PRODUCT MARKET
    • 11.3.1 VISIONARY LEADERS
    • 11.3.2 INNOVATORS
    • 11.3.3 DYNAMIC DIFFERENTIATORS
    • 11.3.4 EMERGING PLAYERS
  • 11.4 COMPETITIVE SITUATION AND TRENDS
    • 11.4.1 PRODUCT & SERVICES LAUNCHES
    • 11.4.2 EXPANSIONS
    • 11.4.3 ACQUISITIONS
    • 11.4.4 OTHER STRATEGIES

12 COMPANY PROFILE

(Business Overview, Products and Services Offered, Recent Developments, and MnM View)*

  • 12.1 ILLUMINA, INC.
  • 12.2 THERMO FISHER SCIENTIFIC, INC.
  • 12.3 GE HEALTHCARE (A WHOLLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • 12.4 PERKINELMER, INC.
  • 12.5 AGILENT TECHNOLOGIES, INC.
  • 12.6 BEIJING GENOMICS INSTITUTE
  • 12.7 F. HOFFMAN-LA ROCHE LTD.
  • 12.8 LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 12.9 NATERA, INC.
  • 12.10 YOURGENE HEALTH
  • Business Overview, Products and Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INCIDENCE RATE OF TRISOMY
  • TABLE 2: RISK OF DOWN SYNDROME WITH INCREASING MATERNAL AGE (GLOBALLY)
  • TABLE 3: COMPARISON OF NON-INVASIVE AND INVASIVE PRENATAL TESTING
  • TABLE 4: NIPT REIMBURSEMENT SCENARIO, BY COUNTRY
  • TABLE 5: PUBLIC HEALTHCARE EXPENDITURE (% OF GDP)
  • TABLE 6: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 7: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 8: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: NIPT CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 10: NIPT CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: NORTH AMERICA: NIPT CONSUMABLES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 12: EUROPE: NIPT CONSUMABLES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 13: NIPT ASSAY KITS AND REAGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: NIPT DISPOSABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: NIPT INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 16: NIPT INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: NORTH AMERICA: NIPT INSTRUMENTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18: EUROPE: NIPT INSTRUMENTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 19: NIPT ULTRASOUND DEVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: NIPT NEXT-GENERATION SEQUENCING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: NIPT PCR INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: NIPT MICROARRAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: OTHER NIPT INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: NIPT SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 26: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 27: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 28: EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 29: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31: EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 32: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN MATERNAL PLASMA TESTS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN MATERNAL PLASMA TESTS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34: EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN MATERNAL PLASMA TESTS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 35: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 36: NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39: NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 40: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 41: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 42: NON-INVASIVE PRENATAL TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 43: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 45: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 46: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 47: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 48: EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 49: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 50: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 51: EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 52: NON-INVASIVE PRENATAL TESTING MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 53: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 54: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 55: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 56: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 57: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 58: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 59: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 60: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 61: US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 62: US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 63: US: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 64: US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 65: CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 66: CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 67: CANADA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 68: CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 69: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 70: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 71: EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 72: EUROPE: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 73: EUROPE: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 74: EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 75: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 76: EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 77: FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 78: FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 79: FRANCE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 80: FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 81: UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 82: UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 83: UK: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 84: UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 85: GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 86: GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 87: GERMANY: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 88: GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 89: THE TABLE BELOW MENTIONS THE MEAN MATERNAL AGE AT FIRST BIRTH IN ROE COUNTRIES:
  • TABLE 90: ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 91: ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 92: ROE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 93: ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 94: ASIA: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 95: ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 96: ASIA: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 97: ASIA: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 99: ASIA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 100: ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 101: ROW: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 102: ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 103: ROW: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 104: ROW: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 105: ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017-2024 (USD MILLION)
  • TABLE 106: ROW: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 107: ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 108: PRODUCT AND SERVICE LAUNCHES, 2016-2018
  • TABLE 109: EXPANSIONS, 2016-2018 109  
  • TABLE 110: ACQUISITIONS, 2016-2018
  • TABLE 111: OTHER STRATEGIES, 2016-2018
  • TABLE 112: EXCHANGE RATE (USED FOR THE CONVERSION OF GBP TO USD)

LIST OF FIGURES

  • FIGURE 1: NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION
  • FIGURE 12: GEOGRAPHICAL SNAPSHOT OF THE NON-INVASIVE PRENATAL TESTING MARKET
  • FIGURE 13: HIGH RISK OF CHROMOSOMAL ABNORMALITIES WITH INCREASING MATERNAL AGE IS A MAJOR FACTOR DRIVING THE ADOPTION OF NON-INVASIVE PRENATAL TESTING
  • FIGURE 14: TRISOMY IS THE FASTEST-GROWING APPLICATION SEGMENT OF THE NIPT MARKET
  • FIGURE 15: ULTRASOUND DETECTION SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2018
  • FIGURE 16: THE NIPT MARKET IN ASIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2019-2024)
  • FIGURE 17: NIPT MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT
  • FIGURE 19: EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT
  • FIGURE 20: KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2016-2018
  • FIGURE 21: GLOBAL NON-INVASIVE PRENATAL TESTING MARKET PLAYER RANKING FOR PRODUCT, 2018
  • FIGURE 22: NIPT MARKET - PRODUCT MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2018
  • FIGURE 23: ILLUMINA, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 24: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 25: GE HEALTHCARE: COMPANY SNAPSHOT (2018)
  • FIGURE 26: PERKINELMER, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 27: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 28: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2018)
  • FIGURE 29: LABCORP: COMPANY SNAPSHOT (2018)
  • FIGURE 30: NATERA, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 31: YOURGENE HEALTH.: COMPANY SNAPSHOT (2018)
Back to Top